Timber Creek Capital Management LLC Buys 1,107 Shares of Elevance Health, Inc. (NYSE:ELV)

Timber Creek Capital Management LLC lifted its position in shares of Elevance Health, Inc. (NYSE:ELV - Free Report) by 17.7% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 7,350 shares of the company's stock after purchasing an additional 1,107 shares during the quarter. Timber Creek Capital Management LLC's holdings in Elevance Health were worth $2,711,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Raelipskie Partnership purchased a new stake in Elevance Health during the third quarter worth approximately $26,000. PSI Advisors LLC acquired a new position in shares of Elevance Health during the 3rd quarter valued at $27,000. Eastern Bank purchased a new stake in Elevance Health during the 3rd quarter worth $31,000. Crews Bank & Trust acquired a new stake in Elevance Health in the 4th quarter valued at $34,000. Finally, Dunhill Financial LLC raised its position in Elevance Health by 57.8% in the third quarter. Dunhill Financial LLC now owns 71 shares of the company's stock valued at $37,000 after purchasing an additional 26 shares during the period. Institutional investors and hedge funds own 89.24% of the company's stock.

Elevance Health Price Performance

Elevance Health stock traded down $5.46 during mid-day trading on Friday, hitting $385.04. The company's stock had a trading volume of 1,736,819 shares, compared to its average volume of 1,621,539. The stock's fifty day moving average price is $385.18 and its two-hundred day moving average price is $445.29. The company has a quick ratio of 1.50, a current ratio of 1.45 and a debt-to-equity ratio of 0.71. The stock has a market capitalization of $89.30 billion, a P/E ratio of 15.03, a P/E/G ratio of 1.18 and a beta of 0.83. Elevance Health, Inc. has a twelve month low of $362.21 and a twelve month high of $567.26.

Elevance Health (NYSE:ELV - Get Free Report) last announced its quarterly earnings data on Thursday, January 23rd. The company reported $3.84 EPS for the quarter, beating analysts' consensus estimates of $3.80 by $0.04. Elevance Health had a net margin of 3.38% and a return on equity of 18.28%. Research analysts forecast that Elevance Health, Inc. will post 34 earnings per share for the current year.

Elevance Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 25th. Stockholders of record on Monday, March 10th will be given a dividend of $1.71 per share. This represents a $6.84 dividend on an annualized basis and a dividend yield of 1.78%. This is a positive change from Elevance Health's previous quarterly dividend of $1.63. The ex-dividend date of this dividend is Monday, March 10th. Elevance Health's dividend payout ratio is presently 25.46%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on ELV shares. StockNews.com raised Elevance Health from a "hold" rating to a "buy" rating in a research report on Tuesday, February 4th. Mizuho decreased their price target on Elevance Health from $585.00 to $505.00 and set an "outperform" rating for the company in a report on Tuesday, November 5th. Stephens lowered Elevance Health from an "overweight" rating to an "equal weight" rating and dropped their target price for the stock from $520.00 to $440.00 in a research report on Wednesday, January 22nd. Wells Fargo & Company cut their price target on shares of Elevance Health from $483.00 to $478.00 and set an "overweight" rating on the stock in a report on Tuesday, January 28th. Finally, Barclays increased their price target on shares of Elevance Health from $501.00 to $512.00 and gave the stock an "overweight" rating in a research report on Friday, January 24th. Three analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $517.03.

Elevance Health Profile

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.